232 related articles for article (PubMed ID: 24920661)
21. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in a Triple-Negative Breast Cancer Patient.
Besemer AE; Grudzinski JJ; Weichert JP; Hall LT; Bednarz BP
Cancer Biother Radiopharm; 2019 Feb; 34(1):13-23. PubMed ID: 30351218
[TBL] [Abstract][Full Text] [Related]
23. Iodine-Rich Polymersomes Enable Versatile SPECT/CT Imaging and Potent Radioisotope Therapy for Tumor in Vivo.
Cao J; Wei Y; Zhang Y; Wang G; Ji X; Zhong Z
ACS Appl Mater Interfaces; 2019 May; 11(21):18953-18959. PubMed ID: 31062589
[TBL] [Abstract][Full Text] [Related]
24. Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT.
Grudzinski JJ; Floberg JM; Mudd SR; Jeffery JJ; Peterson ET; Nomura A; Burnette RR; Tomé WA; Weichert JP; Jeraj R
Phys Med Biol; 2012 Mar; 57(6):1641-57. PubMed ID: 22398155
[TBL] [Abstract][Full Text] [Related]
25. Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma.
Wen X; Shi C; Zhao L; Yao L; Xu D; Lin X; Su X; Liu T; Zhuang R; Lin Q; Chen H; Guo Z; Zhang X
Nucl Med Biol; 2020; 86-87():44-51. PubMed ID: 32474281
[TBL] [Abstract][Full Text] [Related]
26. Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models.
Huang M; Xiong C; Lu W; Zhang R; Zhou M; Huang Q; Weinberg J; Li C
Mol Imaging Biol; 2014 Feb; 16(1):74-84. PubMed ID: 23918654
[TBL] [Abstract][Full Text] [Related]
27. A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies.
Lubner SJ; Mullvain J; Perlman S; Pishvaian M; Mortimer J; Oliver K; Heideman J; Hall L; Weichert J; Liu G
Cancer Invest; 2015; 33(10):483-9. PubMed ID: 26536061
[TBL] [Abstract][Full Text] [Related]
28. Hybrid imaging (SPECT/CT and PET/CT)--improving the diagnostic accuracy of functional/metabolic and anatomic imaging.
Even-Sapir E; Keidar Z; Bar-Shalom R
Semin Nucl Med; 2009 Jul; 39(4):264-75. PubMed ID: 19497403
[TBL] [Abstract][Full Text] [Related]
29.
Alves CRR; Faria DP; Carneiro CG; Garcez AT; Gutierrez VP; das Neves W; de Almeida NR; Cury Y; Chammas R; Brum PC
Life Sci; 2018 Aug; 206():29-34. PubMed ID: 29778807
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and structure-activity relationship effects on the tumor avidity of radioiodinated phospholipid ether analogues.
Pinchuk AN; Rampy MA; Longino MA; Skinner RW; Gross MD; Weichert JP; Counsell RE
J Med Chem; 2006 Apr; 49(7):2155-65. PubMed ID: 16570911
[TBL] [Abstract][Full Text] [Related]
31. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
[TBL] [Abstract][Full Text] [Related]
32. Optimizing dual-time and serial positron emission tomography and single photon emission computed tomography scans for diagnoses and therapy monitoring.
Thie JA
Mol Imaging Biol; 2007; 9(6):348-56. PubMed ID: 17899297
[TBL] [Abstract][Full Text] [Related]
33. Monitoring Tumor Response after Liposomal Doxorubicin in Combination with Liposomal Vinorelbine Treatment Using 3'-Deoxy-3'-[
Wu CY; Tang JH; Chan PC; Li JJ; Lin MH; Shen CC; Liu RS; Wang HE
Mol Imaging Biol; 2017 Jun; 19(3):408-420. PubMed ID: 27730471
[TBL] [Abstract][Full Text] [Related]
34. Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies.
Nayak TK; Bernardo M; Milenic DE; Choyke PL; Brechbiel MW
Radiology; 2013 Apr; 267(1):173-82. PubMed ID: 23329660
[TBL] [Abstract][Full Text] [Related]
35.
Liu F; Zhu H; Yu J; Han X; Xie Q; Liu T; Xia C; Li N; Yang Z
Tumour Biol; 2017 Jun; 39(6):1010428317705519. PubMed ID: 28618966
[TBL] [Abstract][Full Text] [Related]
36. Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles.
Rangger C; Helbok A; Sosabowski J; Kremser C; Koehler G; Prassl R; Andreae F; Virgolini IJ; von Guggenberg E; Decristoforo C
Int J Nanomedicine; 2013; 8():4659-71. PubMed ID: 24353415
[TBL] [Abstract][Full Text] [Related]
37. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer.
Oh JR; Byun BH; Hong SP; Chong A; Kim J; Yoo SW; Kang SR; Kim DY; Song HC; Bom HS; Min JJ
Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1459-68. PubMed ID: 21505897
[TBL] [Abstract][Full Text] [Related]
39. Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer.
Vergez S; Delord JP; Thomas F; Rochaix P; Caselles O; Filleron T; Brillouet S; Canal P; Courbon F; Allal BC
Clin Cancer Res; 2010 Sep; 16(17):4434-45. PubMed ID: 20660574
[TBL] [Abstract][Full Text] [Related]
40. Single-photon emission computed tomography/computed tomography in brain tumors.
Schillaci O; Filippi L; Manni C; Santoni R
Semin Nucl Med; 2007 Jan; 37(1):34-47. PubMed ID: 17161038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
